Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
AbbVie Announces Positive Topline Results from Phase 2 ELATE Trial Evaluating OnabotulinumtoxinA (BOTOX®) for the Treatment of Upper Limb Essential Tremor
Tuesday, October 07, 2025AbbVietoday announced positive topline results from the Phase ELATE trial evaluating the safety and efficacy of onabotulinumtoxinA BOTOX compared to placebo for the treatment of upper limb essential tremor
RoosterBio and Secretome Therapeutics Announce Successful Completion of Large Scale Bioreactor Production for Clinical Stage Cell Therapy Candidate STM-01
Tuesday, October 07, 2025RoosterBio Inc a leading supplier of human mesenchymal stemstromal cells MSCs highly engineered media and bioprocess development services and Secretome Therapeutics a clinicstage company developing
Made Scientific and Syenex Forge Technology Partnership to Transform T Cell Therapy Manufacturing
Wednesday, October 01, 2025Made Scientific a leading cell therapy contract development and manufacturing organization CDMO and Syenex a synthetic biology company specializing in bestinclass targeted delivery technologies
Pharming Group announces U.S. FDA acceptance and Priority Review of supplemental New Drug Application for leniolisib in children with APDS aged 4 to 11 years
Wednesday, October 01, 2025Pharming Group NVtoday announced that the US Food and Drug Administration FDA has accepted its supplemental New Drug Application sNDA seeking approval for leniolisib an oral selective phosphoinositide kinase delta
Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model
Tuesday, September 30, 2025Genmab AS and Merus NV announced today that they have entered into a transaction agreement pursuant to which Genmab intends to acquire all the shares of Merus a clinicalstage biotechnology company with its latestage breakthrough therapy asset petosem...
Imlifidase successfully meets primary endpoint in pivotal US Phase 3 ConfIdeS trial in kidney transplantation
Thursday, September 25, 2025Hansa Biopharma ABtoday announced positive topline results from the US Phase ConfIdeS trial of imlifidase evaluating month kidney function in highly sensitized cPRA adult kidney transplant patients
Hengrui Pharma and Glenmark Pharmaceuticals Enter Exclusive License Agreement for HER2 ADC Trastuzumab Rezetecan (SHR-A1811)
Thursday, September 25, 2025Hengrui Pharmaa leading innovative global pharmaceutical company focused on scientific and technological innovation announced today that it has entered into an exclusive license agreement with Glenmark Specialty SA
Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation
Wednesday, September 24, 2025Sanofi Ventures has announced an additional million multiyear capital commitment from Sanofi increasing its total assets under management to over billion This new commitment to the evergreen
Branded Legacy Inc. Unveils Cutting-Edge GMP Facility to Accelerate Life-Saving Inhaled Naloxone Development
Wednesday, September 24, 2025BioLegacy Evaluative Group Inc a whollyowned subsidiary of Branded Legacy Inc OTC BLEG and an emerging leader in life sciences innovation proudly announces the official opening of its stateoftheart squarefoot Good Manufacturing
Bayer first company to advance cell therapy as well as gene therapy against Parkinson’s disease
Tuesday, September 23, 2025Bayer announced today progress for two potential therapies against Parkinsons disease PD A first participant received randomized treatment in the pivotal Phase III clinical trial exPDite of bemdaneprocel
